Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03629912 · ClinicalTrials.gov registry record · NA
Bingocize: A Novel Mobile Application for Older Adult Health
A NA study, sponsored by Western Kentucky University.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
NCT03629912: Completed NA study, sponsored by Western Kentucky University.
NCT03629912 is a NA study that has completed, run by Western Kentucky University. The registered enrollment target is 241 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03629912, a NA study, has completed, sponsored by Western Kentucky University.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
Study Summary
This study tests the effectiveness of using a new mobile application (Bingocize®) to improve older adults' (a) adherence to an engaging exercise program, and (b) aspects of functional performance, health knowledge, dietary habits, and cognition.
Primary Outcome
Flanker Task designed to measure inhibition, part of the EXAMINER Battery (for scoring method, see References section). EXAMINER generates a score that combines reaction time and accuracy data from the incongruent trials. This scoring method generates accuracy and reaction time sub-scales that range in value between 0 and 5, and the ultimate composite score ranges in value between 0 and 10. Minimum=0, Maximum=10, higher = better.
Interventions
- BEHAVIORAL Socially-Based Exercise Intervention for Older Adults
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2022-05-13 |
| Phase | NA |
What the finished NCT03629912 record still lists
NCT03629912 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Socially-Based Exercise Intervention for Older Adults is the first listed.
NCT03629912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03629912 about?
NCT03629912 is a clinical study titled "Bingocize: A Novel Mobile Application for Older Adult Health". This study tests the effectiveness of using a new mobile application (Bingocize®) to improve older adults' (a) adherence to an engaging exercise program, and (b) aspects of functional performance, health knowledge, dietary habits, and cognition.
What is the current status of trial NCT03629912?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2018-08-13. Estimated completion is 2022-05-13.
What interventions are being tested in trial NCT03629912?
The interventions under investigation include: Socially-Based Exercise Intervention for Older Adults (BEHAVIORAL).
Who is sponsoring clinical trial NCT03629912?
This trial is sponsored by Western Kentucky University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03629912's enrollment target sits among peer trials
241 440th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI